Quinapril/Alpha Lipoic acid

喹那普利/α-硫辛酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameQuinapril/Alpha Lipoic acid
Drug Alias NameQuinapril-Alpha Lipoic acid喹那普利Quinapril+Alpha Lipoic acidα-硫辛酸喹那普利和α-硫辛酸 +[16
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsDiabetes ComplicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A